Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
BackgroundHelicobacter pylori (H. pylori) is highly prevalent worldwide and is closely associated with many gastric conditions. Current methods for eradicating H. pylori include triple or quadruple therapy, including antibiotics, proton pump inhibitors, and bismuth agents; however, with antibiotic a...
Saved in:
Main Authors: | Manning Li, Ying Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1441185/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Saccharomyces Boulardii and Saccharomyces Cerevisiae Improve Immunity in Broilers Vaccinated Against Pasteurella Multocida and Salmonella Gallinarum
by: C Von Mühlen, et al.
Published: (2025-02-01) -
Efficacy analysis of folic acid in chronic atrophic gastritis with Helicobacter pylori infection: a systematic review and meta-analysis
by: Hui Li, et al.
Published: (2025-02-01) -
Infection <i>Helicobacter pylori</i> and stomach cancer: state-of-the-art
by: A. A. Sheptulin
Published: (2012-04-01) -
Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week
by: A. A. Sheptulin, et al.
Published: (2012-09-01) -
Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
by: Ying Wu, et al.
Published: (2025-02-01)